An Updated Model for the First-Time Hospitalization of Patients with Borderline Personality Disorder: Two Illustrative Case Reports

2012 ◽  
Vol 83 (4) ◽  
pp. 391-396 ◽  
Author(s):  
Jonathan Avery ◽  
Dimitry Francois ◽  
Olga Martins ◽  
Steve Park ◽  
Steven Roth
2018 ◽  
Vol 32 (2) ◽  
pp. 207-219 ◽  
Author(s):  
Ester di Giacomo ◽  
Arnoud Arntz ◽  
Maria Fotiadou ◽  
Eugenio Aguglia ◽  
Lavinia Barone ◽  
...  

Borderline personality disorder (BPD) has a core embodied in affective and behavioral dysregulations, impulsivity, and relational disturbance. Clinical presentation might be heterogeneous due to a combination of different symptoms listed in the DSM-5. Clinical diagnosis and assessment of the severity of manifestations might be improved through the administration of structured interviews such as the Borderline Personality Disorder Severity Index, 4th edition (BPDSI-IV). The psychometric properties of the Italian version of the BPDSI-IV were examined for the first time in 248 patients affected by BPD and 113 patients affected by bipolar disorder, proving to be a valid and accurate instrument with good internal consistency and high accuracy. The Italian version also demonstrates significant validity in the discrimination between these clinical groups (p < 5001).


1990 ◽  
Vol 156 (5) ◽  
pp. 752-754
Author(s):  
Mark Berelowitz

A new diagnostic category, borderline personality disorder, was included in the psychiatric classificatory system for the first time when it appeared in the DSM–III (American Psychiatric Association, 1980). However, the label, some of the associated concepts, and of course, the patients, have all been around for much longer. The contemporary concepts have two roots. The first is in the psychoanalytic literature: on the borderline between neurosis and psychosis. These patients are chronically unstable and impulsive, have difficulties in close relationships, and are prone to brief psychotic episodes. The second root is in the general psychiatric literature: on the border of schizophrenia. These patients are cold and aloof, with odd speech, depersonalisation and derealisation, and recurrent illusions. This dual origin will be reflected in the choice of papers and books.


2017 ◽  
Vol 52 (2) ◽  
pp. 117-128 ◽  
Author(s):  
Raelene YM Tan ◽  
Jasmin Grigg ◽  
Jayashri Kulkarni

Objective: This review examines the existing evidence for the relationship between borderline personality disorder and polycystic ovary syndrome, and to identify commonalities in etiological mechanisms of borderline personality disorder and polycystic ovary syndrome that might explain the relationship between these seemingly disparate disorders. Methods: A search of Medline, EMBASE and Cochrane Central was undertaken on 5 December 2016 to identify studies investigating women with borderline personality disorder and polycystic ovary syndrome (or symptoms and markers specific to polycystic ovary syndrome). Results: Nine studies were identified, including three cross-sectional studies investigating symptoms of polycystic ovary syndrome in women with borderline personality disorder, two cross-sectional and one cohort study examining the prevalence of psychiatric diagnoses in women with polycystic ovary syndrome and three case reports of comorbid borderline personality disorder and polycystic ovary syndrome. Conclusion: Overall, the literature shows women with borderline personality disorder to have higher than expected serum androgen levels and incidence of polycystic ovaries, which can be key features of polycystic ovary syndrome. However, this research is still in its infancy, which limits our understanding of this potential comorbid phenomenon. Given the emerging anecdotal and empirical evidence to date, a theoretical discussion of the potential psychoneuroendocrinological mechanism underlying the borderline personality disorder and polycystic ovary syndrome comorbidity is provided. Further rigorous studies using standardized diagnostic criteria for polycystic ovary syndrome are warranted. Specifically, the use of prospective controlled cohort studies may be able to determine the causality and temporality of observed comorbid borderline personality disorder and polycystic ovary syndrome.


2020 ◽  
Vol 11 ◽  
Author(s):  
Tinne Buelens ◽  
Giulio Costantini ◽  
Koen Luyckx ◽  
Laurence Claes

In 2013, DSM-5 urged for further research on non-suicidal self-injury (NSSI) and defined NSSI disorder (NSSI-D) for the first time separate from borderline personality disorder (BPD). However, research on the comorbidity between NSSI-D and BPD symptoms is still scarce, especially in adolescent populations. The current study selected 347 adolescents who engaged at least once in NSSI (78.4% girls, Mage = 15.05) and investigated prevalence, comorbidity, gender differences, and bridge symptoms of NSSI-D and BPD. Network analysis allowed us to visualize the comorbidity structure of NSSI-D and BPD on a symptom-level and revealed which bridge symptoms connected both disorders. Our results supported NSSI-D as significantly distinct from, yet closely related to, BPD in adolescents. Even though girls were more likely to meet the NSSI-D criteria, our findings suggested that the manner in which NSSI-D and BPD symptoms were interconnected, did not differ between girls and boys. Furthermore, loneliness, impulsivity, separation anxiety, frequent thinking about NSSI, and negative affect prior to NSSI were detected as prominent bridge symptoms between NSSI-D and BPD. These bridge symptoms could provide useful targets for early intervention in and prevention of the development of comorbidity between NSSI-D and BPD. Although the current study was limited by a small male sample, these findings do provide novel insights in the complex comorbidity between NSSI-D and BPD symptoms in adolescence.


Sign in / Sign up

Export Citation Format

Share Document